Achieve Life Sciences, Inc. (ACHV)
7.84
-0.65
(-7.66%)
USD |
NASDAQ |
Sep 08, 16:00
7.90
+0.06
(+0.77%)
Pre-Market: 08:37
Achieve Life Sciences Shareholders Equity (Quarterly) : -14.68M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.68M |
| March 31, 2026 | 10.68M |
| December 31, 2025 | 21.52M |
| September 30, 2025 | 33.62M |
| June 30, 2025 | 41.67M |
| March 31, 2025 | 10.28M |
| December 31, 2024 | 20.90M |
| September 30, 2024 | 31.38M |
| June 30, 2024 | 42.28M |
| March 31, 2024 | 49.46M |
| December 31, 2023 | -1.448M |
| September 30, 2023 | 4.038M |
| June 30, 2023 | 9.699M |
| March 31, 2023 | 0.443M |
| December 31, 2022 | 8.303M |
| September 30, 2022 | 1.044M |
| June 30, 2022 | 13.17M |
| March 31, 2022 | 21.43M |
| December 31, 2021 | 28.04M |
| September 30, 2021 | 34.70M |
| June 30, 2021 | 40.85M |
| March 31, 2021 | 30.09M |
| December 31, 2020 | 37.29M |
| September 30, 2020 | 25.68M |
| June 30, 2020 | 14.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.98M |
| December 31, 2019 | 18.05M |
| September 30, 2019 | 8.141M |
| June 30, 2019 | 11.50M |
| March 31, 2019 | 10.19M |
| December 31, 2018 | 15.80M |
| September 30, 2018 | 14.16M |
| June 30, 2018 | 16.44M |
| March 31, 2018 | 6.142M |
| December 31, 2017 | 7.879M |
| September 30, 2017 | 10.68M |
| June 30, 2017 | 13.10M |
| March 31, 2017 | 15.89M |
| December 31, 2016 | 18.97M |
| September 30, 2016 | 24.42M |
| June 30, 2016 | 28.25M |
| March 31, 2016 | 34.22M |
| December 31, 2015 | 37.44M |
| September 30, 2015 | 38.77M |
| June 30, 2015 | 28.19M |
| March 31, 2015 | 30.02M |
| December 31, 2014 | 34.06M |
| September 30, 2014 | 38.85M |
| June 30, 2014 | 26.46M |
| March 31, 2014 | 29.60M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 216.00M |
| ProText Mobility, Inc. | 611.11M |
| ABVC BioPharma, Inc. | 10.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 190.44M |
| Total Liabilities (Quarterly) | 205.12M |
| Debt to Equity Ratio | -1.018 |
| Current Ratio | 0.9526 |
| Net Debt Paydown Yield | -0.15% |